Will tricyclic antidepressants make a comeback for depressed Parkinson disease patients?
Okun
Michael S
MS
Fernandez
Hubert H
HH
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D015283:Citalopram / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy* / Q000209:etiology* / Q000523:psychology; D003891:Desipramine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications* / Q000523:psychology; D016032:Randomized Controlled Trials as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D015283:Citalopram; D003891:Desipramine; D017367:Selective Serotonin Reuptake Inhibitors